Datopotamab deruxtecan induces hallmarks of immunogenic cell death
Antibody-drug conjugates (ADCs) offer a strategy for targeted delivery of cytotoxic agents to cancer cells. In this study, we investigated the mechanism of action of datopotamab deruxtecan, an ADC composed of a monoclonal antibody targeting tumor-associated calcium signal transducer 2 (TACSTD2, also...
Saved in:
| Main Authors: | Sabrina Forveille, Marion Leduc, Allan Sauvat, Guido Kroemer, Oliver Kepp |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shared Science Publishers OG
2025-08-01
|
| Series: | Cell Stress |
| Subjects: | |
| Online Access: | http://microbialcell.com/researcharticles/2025a-forveille-cell-stress |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico decrypting of the bystander effect in antibody–drug conjugates for breast cancer therapy
by: Víctor L. Cruz, et al.
Published: (2025-08-01) -
The efficacy of trastuzumab deruxtecan in Chinese breast cancer patients: a real-world multicenter study
by: Miao He, et al.
Published: (2025-08-01) -
Increasing the odds: antibody-mediated delivery of two distinct immunogenic T-cell epitopes with one antibody
by: Willemijn van der Wulp, et al.
Published: (2025-12-01) -
How macrophages use extracellular calreticulin to chase their prey
by: Liwei Zhao, et al.
Published: (2025-12-01) -
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
by: Juliette Humeau, et al.
Published: (2020-04-01)